LLY

866.44

+0.98%↑

UNH

557.63

-1.37%↓

NVO

133.1

+1.18%↑

JNJ

154.19

-0.25%↓

MRK

125.63

-0.1%↓

LLY

866.44

+0.98%↑

UNH

557.63

-1.37%↓

NVO

133.1

+1.18%↑

JNJ

154.19

-0.25%↓

MRK

125.63

-0.1%↓

LLY

866.44

+0.98%↑

UNH

557.63

-1.37%↓

NVO

133.1

+1.18%↑

JNJ

154.19

-0.25%↓

MRK

125.63

-0.1%↓

LLY

866.44

+0.98%↑

UNH

557.63

-1.37%↓

NVO

133.1

+1.18%↑

JNJ

154.19

-0.25%↓

MRK

125.63

-0.1%↓

LLY

866.44

+0.98%↑

UNH

557.63

-1.37%↓

NVO

133.1

+1.18%↑

JNJ

154.19

-0.25%↓

MRK

125.63

-0.1%↓

Search

Amarin Corp PLC ADR

Отворен

0.79 2.6

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.77

Максимум

0.8

Ключови измерители

By Trading Economics

Приходи

9.4M

-10M

Продажби

-18M

57M

EPS

-0.02

Марж на печалбата

-17.61

EBITDA

-5.5M

-13M

Препоръки

By TipRanks

Препоръки

Продай

12-месечна прогноза

+28.21 upside

Дивиденти

By Dow Jones

Следващи печалби

31.07.2024 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

27M

308M

Предишно отваряне

-1.81

Предишно затваряне

0.79

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Amarin Corp PLC ADR Графика

Свързани новини

21.07.2024 г., 23:16 ч. UTC

Придобивния, сливания и поглъщания

Woodside Doubles Down on U.S., LNG With Tellurian Takeover -- 2nd Update

21.07.2024 г., 23:10 ч. UTC

Придобивния, сливания и поглъщания

Woodside Doubles Down on U.S., LNG With Tellurian Takeover -- Update

21.07.2024 г., 22:53 ч. UTC

Придобивния, сливания и поглъщания

Woodside Doubles Down on U.S., LNG With Tellurian Takeover

21.07.2024 г., 23:53 ч. UTC

Пазарно говорене

Oil Prices Rise in Likely Technical Rebound -- Market Talk

21.07.2024 г., 23:44 ч. UTC

Пазарно говорене

Gold Rises in Likely Technical Recovery -- Market Talk

21.07.2024 г., 23:06 ч. UTC

Придобивния, сливания и поглъщания

Woodside To Acquire Tellurian And Driftwood LNG >WDS.AU

21.07.2024 г., 23:04 ч. UTC

Пазарно говорене

Financial Markets Taking Biden Exit Calmly -- Market Talk

21.07.2024 г., 22:29 ч. UTC

Придобивния, сливания и поглъщания

Woodside Offers $1.00/Share for Tellurian Common Stock

21.07.2024 г., 22:29 ч. UTC

Придобивния, сливания и поглъщания

Tellurian To Be Acquired By Woodside For Approximately $900 Million >TELL WDS.AU

21.07.2024 г., 22:28 ч. UTC

Придобивния, сливания и поглъщания

Woodside: Tellurian Acquisition Includes U.S. Gulf Coast Driftwood LNG Project

21.07.2024 г., 22:28 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy to Acquire Tellurian for Around $900 Million in Cash

21.07.2024 г., 21:55 ч. UTC

Придобивния, сливания и поглъщания

Warehouse: Potential Interest in Acquiring Shares From Tindall, Adamantem Capital Partners

21.07.2024 г., 21:54 ч. UTC

Придобивния, сливания и поглъщания

Warehouse Advises Shareholders Not to Sell Stock, Wait on Directors' Advice

20.07.2024 г., 15:40 ч. UTC

Значими събития в новините

Thousands of Travelers Still Seeing Delays From CrowdStrike Crisis -- Barrons.com

20.07.2024 г., 14:32 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Hathaway Sells Bank of America Stock Worth $1.5 Billion -- Barrons.com

20.07.2024 г., 11:00 ч. UTC

Топ новини
Печалби

Oil-Field Service Companies Ask: Where Did All the Wildcatters Go? -- Heard on the Street -- WSJ

20.07.2024 г., 08:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

20.07.2024 г., 08:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

19.07.2024 г., 22:26 ч. UTC

Значими събития в новините

Airports Paralyzed, Flights Canceled as Microsoft Outage Sparks Worldwide Travel Chaos -- 3rd Update

19.07.2024 г., 21:54 ч. UTC

Значими събития в новините

Major IT Outage Hits Banks, Airlines, Businesses Worldwide -- 13th Update -2-

19.07.2024 г., 21:54 ч. UTC

Топ новини
Значими събития в новините

Major IT Outage Hits Banks, Airlines, Businesses Worldwide -- 13th Update

19.07.2024 г., 21:42 ч. UTC

Печалби
Значими събития в новините

CrowdStrike Insiders Sold Stock Before the Outage. How That Happened. -- Barrons.com

19.07.2024 г., 21:20 ч. UTC

Печалби

Tech Took Down the World on Friday. Is the Market Next? -- Barrons.com

19.07.2024 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

19.07.2024 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

19.07.2024 г., 20:46 ч. UTC

Пазарно говорене

India Defies Slowdown in Private-Equity Exits -- Market Talk

19.07.2024 г., 20:45 ч. UTC

Топ новини

Stocks Drop During Tech Outage at End of Volatile Week -- WSJ

19.07.2024 г., 20:33 ч. UTC

Значими събития в новините

Musk Says Outage Seized Up Auto Supply Chain -- WSJ

19.07.2024 г., 20:20 ч. UTC

Придобивния, сливания и поглъщания

Activist Elliott Takes Big Stake in Starbucks -- Update

19.07.2024 г., 20:13 ч. UTC

Топ новини

Heard on the Street: CrowdStrike May Get More Than a Slap -- WSJ

Сравнение с други в отрасъла

Ценова промяна

Amarin Corp PLC ADR Прогноза

Ценова цел

By TipRanks

28.21% нагоре

12-месечна прогноза

Среден 1 USD  28.21%

Висок 1 USD

Нисък 1 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Amarin Corp PLC ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Продай

2 ratings

0

Купи

1

Задържане

1

Продай

Техническа оценка

By Trading Central

0.739 / 0.8Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Weak Bullish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Amarin Corp PLC ADR

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.